Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.

Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, Sarrazin C, Hoste E, Van Vlierberghe H, Escorsell A, Hafer C, Schreiner O, Galle PR, Mancini E, Caraceni P, Karvellas CJ, Salmhofer H, Knotek M, Ginès P, Kozik-Jaromin J, Rifai K; HELIOS Study Group.

Gastroenterology. 2012 Apr;142(4):782-789.e3. doi: 10.1053/j.gastro.2011.12.056. Epub 2012 Jan 13.

PMID:
22248661
2.

Extracorporeal liver support therapy with Prometheus in patients with liver failure in the intensive care unit.

Oppert M, Rademacher S, Petrasch K, Jörres A.

Ther Apher Dial. 2009 Oct;13(5):426-30. doi: 10.1111/j.1744-9987.2009.00761.x.

PMID:
19788460
3.

Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brünnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Müllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V; RELIEF study group.

Hepatology. 2013 Mar;57(3):1153-62. doi: 10.1002/hep.26185. Epub 2013 Feb 15.

PMID:
23213075
4.

Treatment of Amanita phalloides intoxication by fractionated plasma separation and adsorption (Prometheus®).

Bergis D, Friedrich-Rust M, Zeuzem S, Betz C, Sarrazin C, Bojunga J.

J Gastrointestin Liver Dis. 2012 Jun;21(2):171-6.

5.

The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results.

Skwarek A, Grodzicki M, Nyckowski P, Kotulski M, Zieniewicz K, Michalowicz B, Patkowski W, Grzelak I, Paczkowska A, Giercuszkiewicz D, Sańko-Resmer J, Paczek L, Krawczyk M.

Transplant Proc. 2006 Jan-Feb;38(1):209-11.

PMID:
16504704
6.

Prognostic parameters and risk stratification in intensive care patients with severe liver diseases.

Lehner S, Stemmler HJ, Mück A, Braess J, Parhofer KG.

J Gastrointestin Liver Dis. 2010 Dec;19(4):399-404.

7.

Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.

Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK.

Gastroenterology. 2012 Mar;142(3):505-512.e1. doi: 10.1053/j.gastro.2011.11.027. Epub 2011 Nov 23.

PMID:
22119930
8.

Effectiveness of Fractionated Plasma Separation and Absorption as a Treatment for Amanita Phalloides Poisoning.

Stankiewicz R, Lewandowski Z, Kotulski M, Patkowski W, Krawczyk M.

Ann Transplant. 2016 Jul 8;21:428-32.

9.

[Extracorporeal methods of hematological correction in patients with acute liver insufficiency after cardiac surgery].

Iarustovskiĭ MB, Abramian MV, Komardina EV, Rep'eva EV, Nazarova EI, Krotenko NP, Geptner RA.

Anesteziol Reanimatol. 2014 Sep-Oct;59(5):4-10. Russian.

PMID:
25842933
10.

The effect of fractionated plasma separation and adsorption on cerebral amino acid metabolism and oxidative metabolism during acute liver failure.

Bjerring PN, Hauerberg J, Frederiksen HJ, Nielsen HB, Clemmesen JO, Larsen FS.

J Hepatol. 2012 Oct;57(4):774-9. doi: 10.1016/j.jhep.2012.06.004. Epub 2012 Jun 9.

PMID:
22691571
11.

Prometheus--a new extracorporeal system for the treatment of liver failure.

Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D.

J Hepatol. 2003 Dec;39(6):984-90.

PMID:
14642616
12.

Efficacy of fractionated plasma separation and adsorption system (Prometheus) for treatment of liver failure due to mushroom poisoning.

Vardar R, Gunsar F, Ersoz G, Akarca US, Karasu Z.

Hepatogastroenterology. 2010 May-Jun;57(99-100):573-7.

PMID:
20698230
13.
14.

MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.

Assenza GE, Graham DA, Landzberg MJ, Valente AM, Singh MN, Bashir A, Fernandes S, Mortele KJ, Ukomadu C, Volpe M, Wu F.

Heart. 2013 Apr;99(7):491-6. doi: 10.1136/heartjnl-2012-303347. Epub 2013 Feb 13.

PMID:
23406689
15.

Results of treatment of acute liver failure patients with use of the prometheus FPSA system.

Grodzicki M, Kotulski M, Leonowicz D, Zieniewicz K, Krawczyk M.

Transplant Proc. 2009 Oct;41(8):3079-81. doi: 10.1016/j.transproceed.2009.08.024.

PMID:
19857681
16.

Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption.

Rifai K, Das A, Rosenau J, Ernst T, Kretschmer U, Haller H, Fliser D, Manns MP.

Artif Organs. 2010 Feb;34(2):166-70. doi: 10.1111/j.1525-1594.2009.00763.x. Epub 2009 Oct 10.

PMID:
19817727
17.

Changes in peripheral T-lymphocyte subsets in acute-on-chronic liver failure patients with artificial liver support system.

Lou YF, Dong W, Ye B, Lin S, Mao WL.

Hepatogastroenterology. 2012 May;59(115):814-7. doi: 10.5754/hge10064.

PMID:
22469725
18.

Fractionated plasma separation and adsorption: current practice and future options.

Rifai K.

Liver Int. 2011 Sep;31 Suppl 3:13-5. doi: 10.1111/j.1478-3231.2011.02595.x. Review.

PMID:
21824277
19.

Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study.

Ryska O, Pantoflicek T, Laszikova E, Prazak J, Koblihova E, Ryska M.

Int J Artif Organs. 2012 Jul;35(7):503-10. doi: 10.5301/ijao.5000099.

PMID:
22476878
20.

[Use of fractional plasma separation and adsorption (Prometheus technology) in the treatment of acute liver failure].

Denisova EN, Sharipova VR, Purlo NV, Sukhanova GA, Biriukova LS.

Anesteziol Reanimatol. 2009 Mar-Apr;(2):45-9. Russian.

PMID:
19514440

Supplemental Content

Support Center